RIDMAL TABLETS 3’S

Ridmal is a combination medication that contains Dihydroartemisinin (40 mg) and Piperaquine Phosphate (320 mg). It is primarily used for the treatment of uncomplicated malaria caused by Plasmodium falciparum, the most common and severe malaria parasite. Dihydroartemisinin is an artemisinin derivative that acts quickly to reduce the number of malaria parasites in the blood, while Piperaquine is an antimalarial that helps to eliminate the remaining parasites and prevent relapse. This combination therapy is effective in reducing the risk of developing drug resistance, making it a preferred choice in many malaria-endemic regions. Ridmal is typically administered in a three-day regimen, and it is important for patients to complete the full course of treatment to ensure the infection is fully cleared. Additionally, it may be used in combination with other antimalarial drugs for more severe cases or in specific treatment protocols.